1
|
Garcia-Ruiz A, Sánchez-Domínguez CN, Moncada-Saucedo NK, Pérez-Silos V, Lara-Arias J, Marino-Martínez IA, Camacho-Morales A, Romero-Diaz VJ, Peña-Martinez V, Ramos-Payán R, Castro-Govea Y, Tuan RS, Lin H, Fuentes-Mera L, Rivas-Estilla AM. Sequential growth factor exposure of human Ad-MSCs improves chondrogenic differentiation in an osteochondral biphasic implant. Exp Ther Med 2021; 22:1282. [PMID: 34630637 PMCID: PMC8461520 DOI: 10.3892/etm.2021.10717] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Accepted: 07/28/2021] [Indexed: 11/17/2022] Open
Abstract
Joint cartilage damage affects 10-12% of the world's population. Medical treatments improve the short-term quality of life of affected individuals but lack a long-term effect due to injury progression into fibrocartilage. The use of mesenchymal stem cells (MSCs) is one of the most promising strategies for tissue regeneration due to their ability to be isolated, expanded and differentiated into metabolically active chondrocytes to achieve long-term restoration. For this purpose, human adipose-derived MSCs (Ad-MSCs) were isolated from lipectomy and grown in xeno-free conditions. To establish the best differentiation potential towards a stable chondrocyte phenotype, isolated Ad-MSCs were sequentially exposed to five differentiation schemes of growth factors in previously designed three-dimensional biphasic scaffolds with incorporation of a decellularized cartilage matrix as a bioactive ingredient, silk fibroin and bone matrix, to generate a system capable of being loaded with pre-differentiated Ad-MSCs, to be used as a clinical implant in cartilage lesions for tissue regeneration. Chondrogenic and osteogenic markers were analyzed by reverse transcription-quantitative PCR and cartilage matrix generation by histology techniques at different time points over 40 days. All groups had an increased expression of chondrogenic markers; however, the use of fibroblast growth factor 2 (10 ng/ml) followed by a combination of insulin-like growth factor 1 (100 ng/ml)/TGFβ1 (10 ng/ml) and a final step of exposure to TGFβ1 alone (10 ng/ml) resulted in the most optimal chondrogenic signature towards chondrocyte differentiation and the lowest levels of osteogenic expression, while maintaining stable collagen matrix deposition until day 33. This encourages their possible use in osteochondral lesions, with appropriate properties for use in clinical patients.
Collapse
Affiliation(s)
- Alejandro Garcia-Ruiz
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Celia N Sánchez-Domínguez
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Nidia K Moncada-Saucedo
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Vanessa Pérez-Silos
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Jorge Lara-Arias
- Orthopedics and Traumatology Service, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Iván A Marino-Martínez
- Pathology Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico.,Experimental Therapies Unit, Center for Research and Development in Health Sciences, Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Alberto Camacho-Morales
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico.,Neurometabolism Unit, Center for Research and Development in Health Sciences, Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Víktor J Romero-Diaz
- Histology Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Víctor Peña-Martinez
- Orthopedics and Traumatology Service, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Rosalío Ramos-Payán
- Microbiology Laboratory, Faculty of Chemical-Biological Sciences, Autonomous University of Sinaloa, Culiacan, Sinaloa 80040, Mexico
| | - Yanko Castro-Govea
- Plastic Surgery Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Rocky S Tuan
- Center for Cellular and Molecular Engineering, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA.,McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 15219, USA
| | - Hang Lin
- Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, Pittsburgh, PA 15219, USA
| | - Lizeth Fuentes-Mera
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| | - Ana María Rivas-Estilla
- Biochemistry and Molecular Medicine Department, Faculty of Medicine and University Hospital 'Dr José E. González', Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon 64460, Mexico
| |
Collapse
|
2
|
Trujillo-Villarreal LA, Romero-Díaz VJ, Marino-Martínez IA, Fuentes-Mera L, Ponce-Camacho MA, Devenyi GA, Mallar Chakravarty M, Camacho-Morales A, Garza-Villarreal EE. Maternal cafeteria diet exposure primes depression-like behavior in the offspring evoking lower brain volume related to changes in synaptic terminals and gliosis. Transl Psychiatry 2021; 11:53. [PMID: 33446642 PMCID: PMC7809040 DOI: 10.1038/s41398-020-01157-x] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/13/2020] [Revised: 12/07/2020] [Accepted: 12/10/2020] [Indexed: 02/07/2023] Open
Abstract
Maternal nutritional programming by caloric exposure during pregnancy and lactation results in long-term behavioral modification in the offspring. Here, we characterized the effect of maternal caloric exposure on synaptic and brain morphological organization and its effects on depression-like behavior susceptibility in rats' offspring. Female Wistar rats were exposed to chow or cafeteria (CAF) diet for 9 weeks (pre-pregnancy, pregnancy, and lactation) and then switched to chow diet after weaning. By postnatal day 60, the male Wistar rat offspring were tested for depressive-like behavior using operational conditioning, novelty suppressed feeding, sucrose preference, and open-field test. Brain macro and microstructural morphology were analyzed using magnetic resonance imaging deformation-based morphometry (DBM) and western blot, immunohistochemistry for NMDA and AMPA receptor, synaptophysin and myelin, respectively. We found that the offspring of mothers exposed to CAF diet displayed deficient motivation showing decrease in the operant conditioning, sucrose preference, and suppressed feeding test. Macrostructural DBM analysis showed reduction in the frontomesocorticolimbic circuit volume including the nucleus accumbens (NAc), hippocampus, and prefrontal cortex. Microstructural analysis revealed reduced synaptic terminals in hippocampus and NAc, whereas increased glial fibrillary acidic protein in hippocampus and lateral hypothalamus, as well as a decrease in the hippocampal cell number and myelin reduction in the dentate gyrus and hilus, respectively. Also, offspring exhibited increase of the GluR1 and GLUR2 subunits of AMPA receptor, whereas a decrease in the mGluR2 expression in hippocampus. Our findings reveal that maternal programming might prime depression-like behavior in the offspring by modulating macro and micro brain organization of the frontomesocorticolimbic circuit.
Collapse
Affiliation(s)
- Luis A Trujillo-Villarreal
- Department of Biochemistry, College of Medicine, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México
- Neurometabolism Unit, Center for Research and Development in Health Sciences, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México
| | - Viktor J Romero-Díaz
- Gene therapy Unit, Center for Research and Development in Health Sciences, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México
| | - Iván Alberto Marino-Martínez
- Gene therapy Unit, Center for Research and Development in Health Sciences, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México
| | - Lizeth Fuentes-Mera
- Department of Biochemistry, College of Medicine, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México
| | - Marco Antonio Ponce-Camacho
- Servicio de Anatomía Patológica y Citopatología. Hospital Universitario Dr José Eleuterio González, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México
| | - Gabriel A Devenyi
- Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada
| | - M Mallar Chakravarty
- Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada
- Department of Psychiatry, McGill University, Montreal, QC, Canada
- Department of Biological and Biomedical Engineering, McGill University, Montreal, Canada
| | - Alberto Camacho-Morales
- Department of Biochemistry, College of Medicine, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México.
- Neurometabolism Unit, Center for Research and Development in Health Sciences, Universidad Autónoma de Nuevo León, San Nicolás de los Garza, NL, México.
| | - Eduardo E Garza-Villarreal
- Instituto de Neurobiología, Universidad Nacional Autónoma de México campus Juriquilla, Queretaro, Mexico.
| |
Collapse
|
3
|
Simental-Mendía M, Lozano-Sepúlveda SA, Pérez-Silos V, Fuentes-Mera L, Martínez-Rodríguez HG, Acosta-Olivo CA, Peña-Martínez VM, Vilchez-Cavazos F. Anti‑inflammatory and anti‑catabolic effect of non‑animal stabilized hyaluronic acid and mesenchymal stem cell‑conditioned medium in an osteoarthritis coculture model. Mol Med Rep 2020; 21:2243-2250. [PMID: 32323772 DOI: 10.3892/mmr.2020.11004] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2019] [Accepted: 02/03/2020] [Indexed: 01/15/2023] Open
Abstract
Previous clinical studies have reported the clinical effectiveness of non‑animal stabilized hyaluronic acid (NASHA) and adipose‑derived mesenchymal stromal/stem cells (MSC) in the treatment of knee osteoarthritis (OA). Unlike MSC secreted mediators, in vitro anti‑inflammatory effects of NASHA have not been evaluated. We aimed to evaluate and compare the anti‑inflammatory effect of NASHA and MSC conditioned medium (stem cell‑conditioned medium; SC‑CM), in an explant‑based coculture model of OA. Cartilage and synovial membrane from seven patients undergoing total knee arthroplasty were used to create a coculture system. Recombinant IL‑1β was added to the cocultures to induce inflammation. Four experimental groups were generated: i) Basal; ii) IL‑1β; iii) NASHA (NASHA + IL‑1β); and iv) SC‑CM (SC‑CM + IL‑1β). Glycosaminoglycans (GAG) released in the culture medium and of nitric oxide (NO) production were quantified. Gene expression in cartilage and synovium of IL‑1β, matrix metallopeptidase 13 (MMP13), ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5) and tissue inhibitor of metalloproteinases 1 (TIMP1) was measured by reverse transcription‑quantitative PCR. Media GAG concentration was decreased in cocultures with NASHA and SC‑CM (48 h, P<0.05; 72 h, P<0.01) compared with IL‑1β. Production of NO was significantly lower only in SC‑CM after 72 h (P<0.01). In cartilage, SC‑CM inhibited the expression of IL‑1β, MMP13 and ADAMTS5, while NASHA had this effect only in MMP13 and ADAMTS5. In synovium, SC‑CM decreased the expression level of MMP13 and ADAMTS5, while NASHA only decreased ADAMTS5 expression. Both NASHA and SC‑CM increased TIMP1 expression in cartilage and synovium. Treatments with NASHA and SC‑CM were shown to be a therapeutic option that may help counteract the catabolism produced by the inflammatory state in knee OA. The anti‑inflammatory mediators produced by MSC promote a lower expression of inflammatory targets in our study model.
Collapse
Affiliation(s)
- Mario Simental-Mendía
- Orthopedics and Traumatology Service, School of Medicine and University Hospital 'Dr. José Eleuterio González', Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| | - Sonia Amelia Lozano-Sepúlveda
- Department of Biochemistry and Molecular Medicine, School of Medicine, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| | - Vanessa Pérez-Silos
- Department of Biochemistry and Molecular Medicine, School of Medicine, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| | - Lizeth Fuentes-Mera
- Department of Biochemistry and Molecular Medicine, School of Medicine, Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| | | | - Carlos Alberto Acosta-Olivo
- Orthopedics and Traumatology Service, School of Medicine and University Hospital 'Dr. José Eleuterio González', Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| | - Víctor Manuel Peña-Martínez
- Orthopedics and Traumatology Service, School of Medicine and University Hospital 'Dr. José Eleuterio González', Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| | - Félix Vilchez-Cavazos
- Orthopedics and Traumatology Service, School of Medicine and University Hospital 'Dr. José Eleuterio González', Universidad Autonoma de Nuevo León, Monterrey, Nuevo León 64460, México
| |
Collapse
|
4
|
Cardenas-Perez RE, Fuentes-Mera L, de la Garza AL, Torre-Villalvazo I, Reyes-Castro LA, Rodriguez-Rocha H, Garcia-Garcia A, Corona-Castillo JC, Tovar AR, Zambrano E, Ortiz-Lopez R, Saville J, Fuller M, Camacho A. Maternal overnutrition by hypercaloric diets programs hypothalamic mitochondrial fusion and metabolic dysfunction in rat male offspring. Nutr Metab (Lond) 2018; 15:38. [PMID: 29991958 PMCID: PMC5987395 DOI: 10.1186/s12986-018-0279-6] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Accepted: 05/23/2018] [Indexed: 02/06/2023] Open
Abstract
Background Maternal overnutrition including pre-pregnancy, pregnancy and lactation promotes a lipotoxic insult leading to metabolic dysfunction in offspring. Diet-induced obesity models (DIO) show that changes in hypothalamic mitochondria fusion and fission dynamics modulate metabolic dysfunction. Using three selective diet formula including a High fat diet (HFD), Cafeteria (CAF) and High Sugar Diet (HSD), we hypothesized that maternal diets exposure program leads to selective changes in hypothalamic mitochondria fusion and fission dynamics in male offspring leading to metabolic dysfunction which is exacerbated by a second exposure after weaning. Methods We exposed female Wistar rats to nutritional programming including Chow, HFD, CAF, or HSD for 9 weeks (pre-mating, mating, pregnancy and lactation) or to the same diets to offspring after weaning. We determined body weight, food intake and metabolic parameters in the offspring from 21 to 60 days old. Hypothalamus was dissected at 60 days old to determine mitochondria-ER interaction markers by mRNA expression and western blot and morphology by transmission electron microscopy (TEM). Mitochondrial-ER function was analyzed by confocal microscopy using hypothalamic cell line mHypoA-CLU192. Results Maternal programming by HFD and CAF leads to failure in glucose, leptin and insulin sensitivity and fat accumulation. Additionally, HFD and CAF programming promote mitochondrial fusion by increasing the expression of MFN2 and decreasing DRP1, respectively. Further, TEM analysis confirms that CAF exposure after programing leads to an increase in mitochondria fusion and enhanced mitochondrial-ER interaction, which partially correlates with metabolic dysfunction and fat accumulation in the HFD and CAF groups. Finally, we identified that lipotoxic palmitic acid stimulus in hypothalamic cells increases Ca2+ overload into mitochondria matrix leading to mitochondrial dysfunction. Conclusions We concluded that maternal programming by HFD induces hypothalamic mitochondria fusion, metabolic dysfunction and fat accumulation in male offspring, which is exacerbated by HFD or CAF exposure after weaning, potentially due to mitochondria calcium overflux.
Collapse
Affiliation(s)
- Robbi E Cardenas-Perez
- 1Departmento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.,2Unidad de Neurometabolismo, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico
| | - Lizeth Fuentes-Mera
- 1Departmento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
| | - Ana Laura de la Garza
- 3Centro de Investigacion en Nutricion y Salud Publica, Facultad de Salud Publica y Nutricion, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
| | - Ivan Torre-Villalvazo
- 4Departamento Fisiología de la Nutrición, Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico
| | - Luis A Reyes-Castro
- 5Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran, México City, Mexico
| | - Humberto Rodriguez-Rocha
- 6Departmento de Histología, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
| | - Aracely Garcia-Garcia
- 6Departmento de Histología, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico
| | | | - Armando R Tovar
- 4Departamento Fisiología de la Nutrición, Instituto Nacional de Ciencias Medicas y Nutrición, Mexico City, Mexico
| | - Elena Zambrano
- 5Departamento de Biología de la Reproducción, Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubiran, México City, Mexico
| | - Rocio Ortiz-Lopez
- 8Escuela de Medicina y Ciencias de la Salud, Instituto Tecnologico de Monterrey, Monterrey, Mexico
| | - Jennifer Saville
- Genetics and Molecular Pathology, SA Pathology at Women's and Children's Hospital, University of Adelaide, Adelaide, Australia
| | - Maria Fuller
- Genetics and Molecular Pathology, SA Pathology at Women's and Children's Hospital, University of Adelaide, Adelaide, Australia
| | - Alberto Camacho
- 1Departmento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autonoma de Nuevo Leon, Monterrey, Mexico.,2Unidad de Neurometabolismo, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo Leon, Monterrey, Mexico.,10Departamento de Bioquimica y Medicina Molecular. Facultad de Medicina, Universidad Autónoma de Nuevo León, Ave. Francisco I Madero y Dr. Eduardo Aguirre Pequeño s/n. Colonia Mitras Centro, C.P. 64460 Monterrey, Nuevo Leon Mexico
| |
Collapse
|
5
|
Bermúdez-Reyes B, del Refugio Lara-Banda M, Reyes-Zarate E, Rojas-Martínez A, Camacho A, Moncada-Saucedo N, Pérez-Silos V, García-Ruiz A, Guzmán-López A, Peña-Martínez V, Lara-Arias J, Torres-Méndez S, Fuentes-Mera L. Effect on growth and osteoblast mineralization of hydroxyapatite-zirconia (HA-ZrO
2
) obtained by a new low temperature system. Biomed Mater 2018; 13:035001. [DOI: 10.1088/1748-605x/aaa3a4] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
6
|
Camacho A, Montalvo-Martinez L, Cardenas-Perez RE, Fuentes-Mera L, Garza-Ocañas L. Obesogenic diet intake during pregnancy programs aberrant synaptic plasticity and addiction-like behavior to a palatable food in offspring. Behav Brain Res 2017; 330:46-55. [DOI: 10.1016/j.bbr.2017.05.014] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2017] [Revised: 04/30/2017] [Accepted: 05/04/2017] [Indexed: 02/07/2023]
|
7
|
Flores-Pérez A, Marchat LA, Rodríguez-Cuevas S, Bautista VP, Fuentes-Mera L, Romero-Zamora D, Maciel-Dominguez A, de la Cruz OH, Fonseca-Sánchez M, Ruíz-García E, la Vega HAD, López-Camarillo C. Suppression of cell migration is promoted by miR-944 through targeting of SIAH1 and PTP4A1 in breast cancer cells. BMC Cancer 2016; 16:379. [PMID: 27377268 PMCID: PMC4932667 DOI: 10.1186/s12885-016-2470-3] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2015] [Accepted: 06/29/2016] [Indexed: 11/19/2022] Open
Abstract
Background Aberrant expression of microRNAs has been associated with migration of tumor cells. In this study, we aimed to investigate the biological significance of miR-944 whose function is unknown in breast cancer. Methods MiR-944 expression in breast cancer cells and tumors was evaluated by Taqman qRT-PCR assays. Transcriptional profiling of MDA-MB-231 cells expressing miR-944 was performed using DNA microarrays. Cell viability, migration and invasion were assessed by MTT, scratch/wound-healing and transwell chamber assays, respectively. The luciferase reporter assay was used to evaluate targeting of SIAH1, PTP4A1 and PRKCA genes by miR-944. SIAH1 protein levels were measured by Western blot. Silencing of SIAH1 gene was performed by RNA interference using shRNAs. Results Our data showed that miR-944 expression was severely repressed in clinical specimens and breast cancer cell lines. Suppression of miR-944 levels was independent of hormonal status and metastatic potential of breast cancer cells. Gain-of-function analysis indicated that miR-944 altered the actin cytoskeleton dynamics and impaired cell migration and invasion. Genome-wide transcriptional profiling of MDA-MB-231 cells that ectopically express miR-944 showed that 15 genes involved in migration were significantly repressed. Notably, luciferase reporter assays confirmed the ability of miR-944 to bind the 3´UTR of SIAH1 and PTP4A1 genes, but not PRKCA gene. Congruently, an inverse correlation between miR-944 and SIAH1 protein expression was found in breast cancer cells. Moreover, SIAH1 was upregulated in 75 % of miR-944-deficient breast tumors. Finally, SIAH1 gene silencing by RNA interference significantly impaired cell migration of breast cancer cells. Conclusions Our results pointed out that miR-944 is a novel upstream negative regulator of SIAH1 and PTP4A1 genes and provided for the first time evidence for its functional role in migration and invasion of breast cancer cells. They also suggest that miR-944 restoration may represent a potential strategy for breast cancer therapy. Electronic supplementary material The online version of this article (doi:10.1186/s12885-016-2470-3) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Ali Flores-Pérez
- Universidad Autónoma de la Ciudad de México, Posgrado en Ciencias Genómicas, Ciudad de México, México
| | - Laurence A Marchat
- Programa en Biomedicina Molecular y Red de Biotecnología, Escuela Nacional de Medicina y Homeopatía, Instituto Politécnico Nacional, Ciudad de México, México
| | | | | | | | - Diana Romero-Zamora
- Universidad Autónoma de la Ciudad de México, Posgrado en Ciencias Genómicas, Ciudad de México, México
| | - Anabel Maciel-Dominguez
- Universidad Autónoma de la Ciudad de México, Posgrado en Ciencias Genómicas, Ciudad de México, México
| | - Olga Hernández de la Cruz
- Universidad Autónoma de la Ciudad de México, Posgrado en Ciencias Genómicas, Ciudad de México, México
| | - Miguel Fonseca-Sánchez
- Universidad Autónoma de la Ciudad de México, Posgrado en Ciencias Genómicas, Ciudad de México, México
| | - Erika Ruíz-García
- Laboratorio de Medicina Translacional, Instituto Nacional de Cancerología, Ciudad de México, México
| | - Horacio Astudillo-de la Vega
- Laboratorio de Investigación en Cáncer Translacional y Terapia Celular, Centro Médico Siglo XXI, Ciudad de México, México
| | - César López-Camarillo
- Universidad Autónoma de la Ciudad de México, Posgrado en Ciencias Genómicas, Ciudad de México, México. .,San Lorenzo 290. Col. Del Valle. CP 03100, Mexico City, México.
| |
Collapse
|
8
|
Diaz B, Fuentes-Mera L, Tovar A, Montiel T, Massieu L, Martínez-Rodríguez H, Camacho A. Saturated lipids decrease mitofusin 2 leading to endoplasmic reticulum stress activation and insulin resistance in hypothalamic cells. Brain Res 2015; 1627:80-9. [DOI: 10.1016/j.brainres.2015.09.014] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2015] [Revised: 07/23/2015] [Accepted: 09/10/2015] [Indexed: 02/07/2023]
|
9
|
Leyva-Leyva M, López-Díaz A, Barrera L, Camacho-Morales A, Hernandez-Aguilar F, Carrillo-Casas EM, Arriaga-Pizano L, Calderón-Pérez J, García-Álvarez J, Orozco-Hoyuela G, Piña-Barba C, Rojas-Martínez A, Romero-Díaz V, Lara-Arias J, Rivera-Bolaños N, López-Camarillo C, Moncada-Saucedo N, Galván-De los Santos A, Meza-Urzúa F, Villarreal-Gómez L, Fuentes-Mera L. Differential Expression of Adhesion-Related Proteins and MAPK Pathways Lead to Suitable Osteoblast Differentiation of Human Mesenchymal Stem Cells Subpopulations. Stem Cells Dev 2015; 24:2577-90. [PMID: 26230358 DOI: 10.1089/scd.2015.0070] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Cellular adhesion enables communication between cells and their environment. Adhesion can be achieved throughout focal adhesions and its components influence osteoblast differentiation of human mesenchymal stem cells (hMSCs). Because cell adhesion and osteoblast differentiation are closely related, this article aimed to analyze the expression profiles of adhesion-related proteins during osteoblastic differentiation of two hMSCs subpopulations (CD105(+) and CD105(-)) and propose a strategy for assembling bone grafts based on its adhesion ability. In vitro experiments of osteogenic differentiation in CD105(-) cells showed superior adhesion efficiency and 2-fold increase of α-actinin expression compared with CD105(+) cells at the maturation stage. Interestingly, levels of activated β1-integrin increased in CD105(-) cells during the process. Additionally, the CD105(-) subpopulation showed 3-fold increase of phosphorylated FAK(Y397) compared to CD105(+) cells. Results also indicate that ERK1/2 was activated during CD105(-) bone differentiation and participation of mitogen-activated protein kinase (MAPK)-p38 in CD105(+) differentiation through a focal adhesion kinase (FAK)-independent pathway. In vivo trial demonstrated that grafts containing CD105(-) showed osteocytes embedded in a mineralized matrix, promoted adequate graft integration, increased host vascular infiltration, and efficient intramembranous repairing. In contrast, grafts containing CD105(+) showed deficient endochondral ossification and fibrocartilaginous tissue. Based on the expression of α-actinin, FAKy,(397) and ERK1/2 activation, we define maturation stage as critical for bone graft assembling. By in vitro assays, CD105(-) subpopulation showed superior adhesion efficiency compared to CD105(+) cells. Considering in vitro and in vivo assays, this study suggests that integration of a scaffold with CD105(-) subpopulation at the maturation stage represents an attractive strategy for clinical use in orthopedic bioengineering.
Collapse
Affiliation(s)
- Margarita Leyva-Leyva
- 1 Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
| | - Annia López-Díaz
- 1 Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
| | - Lourdes Barrera
- 2 Laboratorio de Inmunología Integrativa, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas ," México City, México
| | - Alberto Camacho-Morales
- 3 Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México .,4 Unidad de Neurociencias, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| | - Felipe Hernandez-Aguilar
- 1 Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
| | - Erika M Carrillo-Casas
- 1 Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
| | - Lourdes Arriaga-Pizano
- 5 Unidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades Centro Médico Nacional Siglo XXI , IMSS, México City, México
| | - Jaime Calderón-Pérez
- 6 División de Ginecología y Obstetricia, Hospital General "Dr. Manuel Gea González ," México City, México
| | - Jorge García-Álvarez
- 7 Laboratorio de Bioquímica, Facultad de Ciencias, Universidad Nacional Autónoma de México (UNAM) , México City, México
| | - Gabriel Orozco-Hoyuela
- 8 Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM) , México City, México
| | - Cristina Piña-Barba
- 9 Instituto de Investigaciones en Materiales, Universidad Nacional Autónoma de México (UNAM) , México City, México
| | - Augusto Rojas-Martínez
- 3 Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México .,10 Unidad de Terapias Experimentales, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| | - Víktor Romero-Díaz
- 11 Departamento de Histología, Facultad de Medicina , UANL, Monterrey, México .,12 Unidad de Bioimágen, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| | - Jorge Lara-Arias
- 13 Laboratorio de Ingeniería Tisular-Banco de Hueso y Tejidos, Servicio de Ortopedia y Traumatología, Hospital Universitario "Dr. José E. González ," Monterrey, México
| | - Nancy Rivera-Bolaños
- 3 Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México .,10 Unidad de Terapias Experimentales, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| | - César López-Camarillo
- 14 Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México , México City, México
| | - Nidia Moncada-Saucedo
- 3 Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México .,10 Unidad de Terapias Experimentales, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| | - Alejandra Galván-De los Santos
- 3 Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México .,10 Unidad de Terapias Experimentales, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| | - Fátima Meza-Urzúa
- 1 Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General "Dr. Manuel Gea González ," México City, México
| | - Luis Villarreal-Gómez
- 15 Centro de Ingeniería y Tecnología (CITEC), Universidad Autónoma de Baja California , Baja California, Tijuana, México
| | - Lizeth Fuentes-Mera
- 3 Departamento de Bioquímica y Medicina Molecular, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México .,10 Unidad de Terapias Experimentales, Centro de Investigación y Desarrollo en Ciencias de la Salud, Universidad Autónoma de Nuevo León (UANL) , Monterrey, México
| |
Collapse
|
10
|
Delint-Ramirez I, Maldonado Ruiz R, Torre-Villalvazo I, Fuentes-Mera L, Garza Ocañas L, Tovar A, Camacho A. Genetic obesity alters recruitment of TANK-binding kinase 1 and AKT into hypothalamic lipid rafts domains. Neurochem Int 2015; 80:23-32. [DOI: 10.1016/j.neuint.2014.11.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2014] [Revised: 10/31/2014] [Accepted: 11/04/2014] [Indexed: 10/24/2022]
|
11
|
Díaz-Chávez J, Fonseca-Sánchez MA, Arechaga-Ocampo E, Flores-Pérez A, Palacios-Rodríguez Y, Domínguez-Gómez G, Marchat LA, Fuentes-Mera L, Mendoza-Hernández G, Gariglio P, López-Camarillo C. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS One 2013; 8:e64378. [PMID: 23724044 PMCID: PMC3664632 DOI: 10.1371/journal.pone.0064378] [Citation(s) in RCA: 54] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2013] [Accepted: 04/11/2013] [Indexed: 02/03/2023] Open
Abstract
The use of chemopreventive natural compounds represents a promising strategy in the search for novel therapeutic agents in cancer. Resveratrol (3,4′,5-trans-trihydroxystilbilene) is a dietary polyphenol found in fruits, vegetables and medicinal plants that exhibits chemopreventive and antitumor effects. In this study, we searched for modulated proteins with preventive or therapeutic potential in MCF-7 breast cancer cells exposed to resveratrol. Using two-dimensional electrophoresis we found significant changes (FC >2.0; p≤0.05) in the expression of 16 proteins in resveratrol-treated MCF-7 cells. Six down-regulated proteins were identified by tandem mass spectrometry (ESI-MS/MS) as heat shock protein 27 (HSP27), translationally-controlled tumor protein, peroxiredoxin-6, stress-induced-phosphoprotein-1, pyridoxine-5′-phosphate oxidase-1 and hypoxanthine-guanine phosphoribosyl transferase; whereas one up-regulated protein was identified as triosephosphate isomerase. Particularly, HSP27 overexpression has been associated to apoptosis inhibition and resistance of human cancer cells to therapy. Consistently, we demonstrated that resveratrol induces apoptosis in MCF-7 cells. Apoptosis was associated with a significant increase in mitochondrial permeability transition, cytochrome c release in cytoplasm, and caspases -3 and -9 independent cell death. Then, we evaluated the chemosensitization effect of increasing concentrations of resveratrol in combination with doxorubicin anti-neoplastic agent in vitro. We found that resveratrol effectively sensitize MCF-7 cells to cytotoxic therapy. Next, we evaluated the relevance of HSP27 targeted inhibition in therapy effectiveness. Results evidenced that HSP27 inhibition using RNA interference enhances the cytotoxicity of doxorubicin. In conclusion, our data indicate that resveratrol may improve the therapeutic effects of doxorubicin in part by cell death induction. We propose that potential modulation of HSP27 levels using natural alternative agents, as resveratrol, may be an effective adjuvant in breast cancer therapy.
Collapse
Affiliation(s)
- José Díaz-Chávez
- Carcinogenesis Laboratory, National Institute of Cancerology, Mexico City, Mexico
| | - Miguel A. Fonseca-Sánchez
- Oncogenomics and Cancer Proteomics Laboratory, Genomics Sciences Program, Autonomous University of Mexico City, Mexico City, Mexico
| | | | - Ali Flores-Pérez
- Oncogenomics and Cancer Proteomics Laboratory, Genomics Sciences Program, Autonomous University of Mexico City, Mexico City, Mexico
| | - Yadira Palacios-Rodríguez
- Oncogenomics and Cancer Proteomics Laboratory, Genomics Sciences Program, Autonomous University of Mexico City, Mexico City, Mexico
| | | | - Laurence A. Marchat
- Molecular Biomedicine Program and Biotechnology Network, National School of Medicine and Homeopathy, National Polytechnic Institute, Mexico City, Mexico
| | - Lizeth Fuentes-Mera
- Molecular Biology and Histocompatibility Laboratory, General “Dr. Manuel Gea González” Hospital, Mexico City, Mexico
| | | | - Patricio Gariglio
- Genetics and Molecular Biology Department, Center of Research and Advances Studies, Mexico City, Mexico
| | - César López-Camarillo
- Oncogenomics and Cancer Proteomics Laboratory, Genomics Sciences Program, Autonomous University of Mexico City, Mexico City, Mexico
- * E-mail:
| |
Collapse
|
12
|
Leyva-Leyva M, Barrera L, López-Camarillo C, Arriaga-Pizano L, Orozco-Hoyuela G, Carrillo-Casas EM, Calderón-Pérez J, López-Díaz A, Hernandez-Aguilar F, González-Ramírez R, Kawa S, Chimal-Monroy J, Fuentes-Mera L. Characterization of Mesenchymal Stem Cell Subpopulations from Human Amniotic Membrane with Dissimilar Osteoblastic Potential. Stem Cells Dev 2013; 22:1275-87. [DOI: 10.1089/scd.2012.0359] [Citation(s) in RCA: 55] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Affiliation(s)
- Margarita Leyva-Leyva
- Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General “Dr. Manuel Gea González”, México, México
| | - Lourdes Barrera
- Laboratorio de Inmunología Integrativa, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, México, México
| | - César López-Camarillo
- Laboratorio de Oncogenómica y Proteómica del Cáncer, Posgrado en Ciencias Genómicas, Universidad Autónoma de la Ciudad de México, México, México
| | - Lourdes Arriaga-Pizano
- Unidad de Investigación Médica en Inmunoquímica, Hospital de Especialidades, Centro Médico Nacional, Siglo XXI, IMSS, México, México
| | - Gabriel Orozco-Hoyuela
- Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM), México, México
| | - Erika M. Carrillo-Casas
- Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General “Dr. Manuel Gea González”, México, México
| | - Jaime Calderón-Pérez
- División de Ginecología y Obstetricia, Hospital General “Dr. Manuel Gea González”, México, México
| | - Annia López-Díaz
- Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General “Dr. Manuel Gea González”, México, México
| | - Felipe Hernandez-Aguilar
- Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General “Dr. Manuel Gea González”, México, México
| | - Ricardo González-Ramírez
- Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General “Dr. Manuel Gea González”, México, México
| | - Simón Kawa
- Comisión Nacional de Bioética, México, México
| | - Jesús Chimal-Monroy
- Departamento de Medicina Genómica y Toxicología Ambiental, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (UNAM), México, México
| | - Lizeth Fuentes-Mera
- Laboratorio de Biología Molecular e Histocompatibilidad, Dirección de Investigación Hospital General “Dr. Manuel Gea González”, México, México
| |
Collapse
|
13
|
Lara-Chacón B, de León MB, Leocadio D, Gómez P, Fuentes-Mera L, Martínez-Vieyra I, Ortega A, Jans DA, Cisneros B. Characterization of an Importin α/β-recognized nuclear localization signal in β-dystroglycan. J Cell Biochem 2010; 110:706-17. [DOI: 10.1002/jcb.22581] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
14
|
Fuentes-Mera L, Rodríguez-Muñoz R, González-Ramírez R, García-Sierra F, González E, Mornet D, Cisneros B. Characterization of a novel Dp71 dystrophin-associated protein complex (DAPC) present in the nucleus of HeLa cells: members of the nuclear DAPC associate with the nuclear matrix. Exp Cell Res 2006; 312:3023-35. [PMID: 16824516 DOI: 10.1016/j.yexcr.2006.06.002] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2006] [Revised: 05/06/2006] [Accepted: 06/02/2006] [Indexed: 11/26/2022]
Abstract
Dystrophin is an essential component in the assembly and maintenance of the dystrophin-associated protein complex (DAPC), which includes members of the dystroglycan, syntrophin, sarcoglycan and dystrobrevin protein families. Distinctive complexes have been described in the cell membrane of different tissues and cultured cells. In this work, we report the identification and characterization of a novel DAPC present in the nuclei of HeLa cells, which contains dystrophin Dp71 as a key component. Using confocal microscopy and cell fractionation analyses, we found the presence of Dp71, beta-sarcoglycan, beta-dystroglycan, alpha- and beta-syntrophin, alpha1- and beta-dystrobrevin and nNOS in the nuclei of HeLa cells. Furthermore, we demonstrated by co-immunoprecipitation experiments that most of these proteins form a complex in the nuclear compartment. Next, we analyze the possible association of the nuclear DAPC with the nuclear matrix. We found the presence of Dp71, beta-dystroglycan, nNOS, beta-sarcoglycan, alpha/beta syntrophin, alpha1-dystrobrevin and beta-dystrobrevin in the nuclear matrix protein fractions and in situ nuclear matrix preparations from HeLa cells. Moreover, we found that Dp71, beta-dystroglycan and beta-dystrobrevin co-immunoprecipitated with the nuclear matrix proteins lamin B1 and actin. The association of members of the nuclear DAPC with the nuclear matrix indicates that they may work as scaffolding proteins involved in nuclear architecture.
Collapse
Affiliation(s)
- Lizeth Fuentes-Mera
- Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del IPN, Avenida Instituto Politécnico Nacional 2508, Apartado Postal 14-740, C.P. 07000, México D.F., México
| | | | | | | | | | | | | |
Collapse
|
15
|
Acosta R, Montañez C, Fuentes-Mera L, Gonzalez E, Gómez P, Quintero-Mora L, Mornet D, Alvarez-Salas LM, Cisneros B. Dystrophin Dp71 is required for neurite outgrowth in PC12 cells. Exp Cell Res 2004; 296:265-75. [PMID: 15149856 DOI: 10.1016/j.yexcr.2004.01.015] [Citation(s) in RCA: 36] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2003] [Revised: 01/16/2004] [Indexed: 11/22/2022]
Abstract
To determine the role of Dp71 in neuronal cells, we generated PC12 cell lines in which Dp71 protein levels were controlled by stable transfection with either antisense or sense constructs. Cells expressing the antisense Dp71 RNA (antisense-Dp71 cells) contained reduced amounts of the two endogenous Dp71 isoforms. Antisense-Dp71 cells exhibited a marked suppression of neurite outgrowth upon the induction with NGF or dibutyryl cyclic AMP. Early responses to NGF-induced neuronal differentiation, such as the cessation of cell division and the activation of ERK1/2 proteins, were normal in the antisense-Dp71 cells. On contrary, the induction of MAP2, a late differentiation marker, was disturbed in these cells. Additionally, the deficiency of Dp71 correlated with an altered expression of the dystrophin-associated protein complex (DAPC) members alpha and beta dystrobrevins. Our results indicate that normal expression of Dp71 is essential for neurite outgrowth in PC12 cells and constitute the first direct evidence implicating Dp71 in a neuronal function.
Collapse
Affiliation(s)
- Rosalinda Acosta
- Department of Genetics and Molecular Biology, Centro de Investigación y de Estudios Avanzados del IPN, Avenida Instituto Politécnico Nacional 2508, Apartado Postal 14-740, C.P. 07000, Mexico D.F., Mexico
| | | | | | | | | | | | | | | | | |
Collapse
|